MEDISCO Praha, s.r.o.
The company MEDISCO Praha, s.r.o. (together with its subsidiary MEDISCO, a.s.) was established in 1992 as a distributor of medical devices and medicines. Over the years, the company has established itself mainly as a distributor of in vitro diagnostic and examination analyzers. We cooperate and supply in vitro diagnostics mainly into laboratories of immunology, biochemistry / hematology, microbiology, including laboratories of molecular biology. We also cooperate with research institutions on grants and projects.
We rely on long-term cooperation with quality suppliers, on monitoring current trends in laboratory diagnostics, on an experienced team of sales representatives and also on flexibility in improving services to our clients. The company has its own warehouse and delivery. Activities of the company are audited and certified according to ISO 13485 edition 2: 2016 by CQS (IQNet).
News
SARS-CoV-2 Variants II mutation S gene (P681R, L452R and E484Q)
qRt-PCR
allows the qualitative detection of RNA from genetic mutations in the S gene (P681R, L452R and E484Q) by real-time RT-PCR in positive SARS-CoV-2 nasopharyngeal samples.
SARS-CoV-2 Variants mutation S gene (E484K, K417N, K417T and N501Y)
allows the qualitative detection of RNA from genetic mutations in the S gene (E484K, K417N, K417T and N501Y) by real-time RT-PCR in positive SARS-CoV-2 nasopharyngeal samples.
